Epigenomics AG Stock Deutsche Boerse AG
Stocks
ECX
DE000A11QW50
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.785 EUR | -1.92% |
|
+9.51% | -4.03% |
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 22/07/25 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 767K 876K 708K 662K 1.25M 82.86M 1.27M 8.52M 3.29M 40.88M 3.29M 3.22M 142M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.73M 13.4M 10.83M 10.12M 19.04M 1.27B 19.48M 130M 50.33M 625M 50.33M 49.22M 2.17B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.92% |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 01/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 01/03/2023 |
Alexander Link
BRD | Director/Board Member | 55 | 01/06/2020 |
Jochen Hummel
BRD | Director/Board Member | 56 | 05/02/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.92% | +9.51% | - | - | 870K | |
| -0.50% | +13.16% | +119.83% | +132.75% | 4.83B | |
| +2.10% | +23.20% | +81.51% | +213.78% | 3.35B | |
| +3.58% | -1.86% | -26.99% | -40.38% | 1.96B | |
| -0.94% | +3.69% | +149.11% | -40.28% | 1.9B | |
| +1.60% | +16.89% | +52.26% | +242.06% | 1.49B | |
| +2.73% | +21.71% | +158.70% | -48.92% | 917M | |
| +8.75% | +12.36% | -7.73% | +47.82% | 842M | |
| +1.59% | -4.87% | -37.37% | -18.92% | 466M | |
| +17.16% | -7.72% | +16.56% | - | 435M | |
| Average | +3.42% | +9.39% | +56.21% | +60.99% | 1.8B | |
| Weighted average by Cap. | +1.87% | +11.88% | +79.63% | +98.38% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.41K 22.16K 20.69K 38.95K 2.59M 39.83K 267K 103K 1.28M 103K 101K 4.44M |
| Net income | -3.35M -3.83M -3.09M -2.89M -5.44M -362M -5.56M -37.24M -14.38M -179M -14.38M -14.06M -620M | -314K -359K -290K -271K -510K -33.9M -521K -3.49M -1.35M -16.73M -1.35M -1.32M -58.07M |
| Net Debt | 10.46M 11.94M 9.65M 9.01M 16.97M 1.13B 17.35M 116M 44.84M 557M 44.84M 43.86M 1.93B | 10.97M 12.53M 10.12M 9.45M 17.8M 1.18B 18.2M 122M 47.03M 584M 47.04M 46M 2.03B |
Employees
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ECX Stock
- ECX Stock
Select your edition
All financial news and data tailored to specific country editions
